title: Safety and efficacy of BIOSYNSORB immunoadsorption column treatment.
authors.affiliation: National Institute of Transplantation, Los Angeles, California 90057.
authors.forename: L M
authors.initials: LM
authors.lastname: Sakhrani
authors.forename: R
authors.initials: R
authors.lastname: Minasian
authors.forename: S
authors.initials: S
authors.lastname: Aswad
authors.forename: E
authors.initials: E
authors.lastname: Obispo
authors.forename: R
authors.initials: R
authors.lastname: Mendez
authors.forename: R G
authors.initials: RG
authors.lastname: Mendez
mesh_terms: D000017:ABO Blood-Group System / Q000276:immunology*; D001323:Autoantibodies / Q000302:isolation & purification*; D001787:Blood Group Incompatibility; D006464:Hemoperfusion / Q000295:instrumentation / Q000379:methods*; D006801:Humans; D007075:Immunoglobulin M / Q000097:blood* / Q000302:isolation & purification; D007163:Immunosorbent Techniques; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D016896:Treatment Outcome
chemical_list: D000017:ABO Blood-Group System; D001323:Autoantibodies; D007075:Immunoglobulin M; D007166:Immunosuppressive Agents